Cytokine gene expression during the development of graft coronary artery disease in mice

被引:11
作者
Furukawa, Y [1 ]
Matsumori, A [1 ]
Hwang, MW [1 ]
Hirozane, T [1 ]
Ono, K [1 ]
Shioi, T [1 ]
Sasayama, S [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 606, Japan
来源
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION | 1999年 / 63卷 / 10期
关键词
cytokine; graft coronary artery disease; heart transplantation; mouse;
D O I
10.1253/jcj.63.775
中图分类号
N09 [自然科学史]; B [哲学、宗教];
学科分类号
01 ; 0101 ; 010108 ; 060207 ; 060305 ; 0712 ;
摘要
Immunologic injury to heart allografts is an initial and essential event in the pathogenesis of graft coronary artery disease (GAD). A variety of cytokines expressed in heart allografts modify both acute rejection and chronic inflammation, and could contribute to the development of GAD. The present study investigated the gene expression of interleukin (IL)-1b, IL-2, IL-4, IL-6, IL-10, tumor necrosis factor (TNF)-a, interferon (IFN)-g, and Fas ligand in chronically rejecting DBA/2-to-B10.D2 mouse heart allografts at defined intervals of 7, 14, 28, or 70 days after transplantation by semiquantitative reverse transcriptase-polymerase chain reaction. GAD developed gradually, showing the highest value for mean intima/media ratio at day 70. Fas ligand, and the Th1 cytokines IL-2 and IFN-g, were vigorously induced in allografts at day 7, when histology showed pronounced parenchymal rejection, and rapidly decreased by day 28. However, the level of mRNA expression of Th2 cytokines, IL-6 and IL-10, and other inflammatory cytokines, INF-a and IL-1 beta, were still elevated on day 28. The persistent expression of specific cytokines suggests an important role in chronic inflammation. Thus, a persistently high level expression of inflammatory cytokines could be associated with chronic inflammation in the allografts, which promotes the development of GAD.
引用
收藏
页码:775 / 782
页数:8
相关论文
共 59 条
[1]  
Alexander D Z, 1996, Transpl Immunol, V4, P46, DOI 10.1016/S0966-3274(96)80033-5
[2]   Association of mild hyperhomocysteinemia with cardiac graft vascular disease [J].
Ambrosi, P ;
Garçon, D ;
Riberi, A ;
Habib, G ;
Barlatier, A ;
Kreitmann, B ;
Rolland, PH ;
Bouvenot, G ;
Luccioni, R ;
Métras, D .
ATHEROSCLEROSIS, 1998, 138 (02) :347-350
[3]  
BARATH P, 1990, AM J PATHOL, V137, P503
[4]  
BERGESE S, 1995, AM J PATHOL, V146, P989
[5]   MOLECULAR MECHANISMS OF TUMOR NECROSIS FACTOR-INDUCED CYTOTOXICITY - WHAT WE DO UNDERSTAND AND WHAT WE DO NOT [J].
BEYAERT, R ;
FIERS, W .
FEBS LETTERS, 1994, 340 (1-2) :9-16
[6]  
BIEBER CP, 1981, TRANSPLANT P, V13, P207
[7]  
BILLINGHAM ME, 1989, TRANSPLANT P, V21, P3665
[8]   INTERLEUKIN-1 PROMOTES PROLIFERATION OF VASCULAR SMOOTH-MUSCLE CELLS IN COORDINATION WITH PDGF OR A MONOCYTE DERIVED GROWTH-FACTOR [J].
BONIN, PD ;
FICI, GJ ;
SINGH, JP .
EXPERIMENTAL CELL RESEARCH, 1989, 181 (02) :475-482
[9]   Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease [J].
Brunner-La Rocca, HP ;
Schneider, J ;
Künzli, A ;
Turina, M ;
Kiowski, W .
TRANSPLANTATION, 1998, 65 (04) :538-543
[10]   IN-VIVO DEPLETION OF CD8+ T-CELLS RESULTS IN TH2 CYTOKINE PRODUCTION AND ALTERNATE MECHANISMS OF ALLOGRAFT-REJECTION [J].
CHAN, SY ;
DEBRUYNE, LA ;
GOODMAN, RE ;
EICHWALD, EJ ;
BISHOP, DK .
TRANSPLANTATION, 1995, 59 (08) :1155-1161